Bulbrite Industries

Beam Therapeutics | August 12, 2020

Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83 million manufacturing facility in North Carolina’s Research Triangle Park, it was announced today. The uptick: the addition of 201 jobs with an average salary of around $102,654. “North Carolina is a leader in biotechnology, from the research in our labs to the state’s biomanufacturers,” said Governor Roy Coope...

manufacturing | February 05, 2021

Luokung Technology Corp. (NASDAQ: LKCO) has led an interactive location-based services in China. It has announced eMapgo Technologies (Beijing) Co., Ltd. ("EMG") and Beijing New Energy Automobile Co., Ltd. (BAIC BluePark New Energy Technology Co., Ltd., Ticker: 600733.SH) ("BAIC BJEV") have decided to associate with the development of autonomous driving projects for BAIC BJEV's electric vehicles (EVs). EMG already worked with BAIC BJEV and provided HD map s...

Manufacturing Global | March 17, 2020

Electric vehicle maker Tesla will be allowed to continue operating its Fremont factory as the San Francisco Bay Area begins a three-week lockdown to rein in the spread of coronavirus, the Los Angeles Times reported. Tesla’s sole US auto factory in Alameda County employs more than 10,000 workers and had annualised production of slightly over 415,000 units by the fourth quarter. The county is one of six covered by a ‘shelter in place’ order from regional authorities that limits a...

Essentium, Inc., Hephzibah | July 13, 2020

Essentium, Inc., a leading innovator of industrial additive manufacturing (AM) solutions, today announced a distribution partnership with Hephzibah, prominent South Korean 3D printing specialist, to advance additive manufacturing in South Korea. The combination of Hephzibah’s best-in-class service, customer support, and use-case specific expertise, together with the ground-breaking speed and economics of the Essentium High Speed Extrusion (HSETM) 3D Printing Platform will he...